Heterogeneity in Host Risk Factors for Incident Melanoma and Non-Melanoma Skin Cancer in a Cohort of US Women

被引:27
|
作者
Qureshi, Abrar A. [1 ,2 ,3 ]
Zhang, Mingfeng [1 ,3 ,4 ]
Han, Jiali [1 ,2 ,3 ,5 ]
机构
[1] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Nanjing Med Univ, Ctr Canc, Dept Epidemiol & Biostat, Nanjing, Peoples R China
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA
关键词
melanoma; squamous cell carcinoma; basal cell carcinoma; phenotype; SQUAMOUS-CELL CARCINOMA; BASAL-CELL; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; SUN EXPOSURE; QUESTIONNAIRE; SENSITIVITY; POPULATION; HYPOTHESIS; PHENOTYPE;
D O I
10.2188/jea.JE20100145
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Melanoma, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC) are 3 types of skin cancer that have distinct biologic characteristics and prognoses. We evaluated phenotypic differences in the risk of these cancers in US women. Methods: We conducted a prospective study of 113 139 female nurses from 1984 to 2002. Over the 18 years of follow-up, there were 375 cases of melanoma, 495 cases of SCC, and 9423 cases of BCC. Results: Women with melanoma were more likely to have a family history of melanoma (melanoma: RR 1.94, 95% confidence interval [CI] 1.36-2.76; SCC: RR 0.82, 95% CI 0.58-1.37; BCC: RR 1.49, 95% Cl 1.38-1.62) and 6 or more moles on the left arm (melanoma: RR 3.66, 95% CI 2.15-6.24; SCC: RR 1.53, 95% CI 0.83-2.79; BCC: RR 1.48, 95% CI 1.28-1.72). Polytomous logistic regression analysis showed that age at diagnosis (P < 0.0001), family history of melanoma (P = 0.016), and number of moles on the left arm (P = 0.007) were significantly different across the 3 cancers. Conclusions: This prospective observational study demonstrated that known phenotypic factors for skin cancer have a differential impact on the risk of melanoma, SCC, and BCC.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 50 条
  • [41] United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019
    Aggarwal, Pushkar
    Knabel, Peter
    Fleischer, Alan B., Jr.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (02) : 388 - 395
  • [42] Citrus Consumption and Risk of Non-Melanoma Skin Cancer in the UK Biobank
    Marley, Andrew R.
    Li, Ming
    Champion, Victoria L.
    Song, Yiqing
    Han, Jiali
    Li, Xin
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (03): : 810 - 815
  • [43] Cetuximab in non-melanoma skin cancer
    Wollina, Uwe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (07) : 949 - 956
  • [44] Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: Review of the literature
    Miguel Garrido, Pedro
    Borges-Costa, Joao
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2020, 39 (03) : 163 - 170
  • [45] Alcohol consumption and risk of melanoma and non-melanoma skin cancer in the Women’s Health Initiative
    Jessica T. Kubo
    Michael T. Henderson
    Manisha Desai
    Jean Wactawski-Wende
    Marcia L. Stefanick
    Jean Y. Tang
    Cancer Causes & Control, 2014, 25 : 1 - 10
  • [46] Evolving Role of Systemic Therapies in Non-melanoma Skin Cancer
    Conforti, C.
    Corneli, P.
    Harwood, C.
    Zalaudek, I.
    CLINICAL ONCOLOGY, 2019, 31 (11) : 759 - 768
  • [47] Personal history of non-melanoma skin cancer diagnosis and death from melanoma in women
    Chen, Steven T.
    Li, Xin
    Han, Jiali
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (08) : 1536 - 1541
  • [48] The Immune System and Pathogenesis of Melanoma and Non-melanoma Skin Cancer
    Schrom, Kory P.
    Kim, InYoung
    Baron, Elma D.
    SUNLIGHT, VITAMIN D AND SKIN CANCER, 3RD EDITION, 2020, 1268 : 211 - 226
  • [49] Socioeconomic status and non-melanoma skin cancer: A nationwide cohort study of incidence and survival in Denmark
    Steding-Jessen, M.
    Birch-Johansen, F.
    Jensen, A.
    Schuz, J.
    Kjaer, S. K.
    Dalton, S. O.
    CANCER EPIDEMIOLOGY, 2010, 34 (06) : 689 - 695
  • [50] Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer
    Durante, Giorgio
    Broseghini, Elisabetta
    Comito, Francesca
    Naddeo, Maria
    Milani, Massimo
    Salamon, Irene
    Campione, Elena
    Dika, Emi
    Ferracin, Manuela
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (03) : 305 - 318